{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:48:27Z","timestamp":1782175707151,"version":"3.54.5"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":75,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA222274"],"award-info":[{"award-number":["R01CA222274"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA255196"],"award-info":[{"award-number":["R01CA255196"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA272866"],"award-info":[{"award-number":["R01CA272866"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA282704"],"award-info":[{"award-number":["R01CA282704"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-70816-2","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T17:07:21Z","timestamp":1775754441000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CRISPR activation screens identify oncogenic lncRNAs that are susceptible to CDK4\/6 inhibitor treatment"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2832-4125","authenticated-orcid":false,"given":"Yifei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueshan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1691-7820","authenticated-orcid":false,"given":"Jiaxin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0769-8865","authenticated-orcid":false,"given":"Zehua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4995-1264","authenticated-orcid":false,"given":"Dhamotharan","family":"Pattarayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sihan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9415-5294","authenticated-orcid":false,"given":"Xiaofei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3967-155X","authenticated-orcid":false,"given":"Wen","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8336-9457","authenticated-orcid":false,"given":"Da","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,9]]},"reference":[{"key":"70816_CR1","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou, C. M. et al. Molecular portraits of human breast tumours. Nature 406, 747\u2013752 (2000).","journal-title":"Nature"},{"key":"70816_CR2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nature11412","volume":"490","author":"N Cancer Genome Atlas","year":"2012","unstructured":"Cancer Genome Atlas, N. Comprehensive molecular portraits of human breast tumours. Nature 490, 61\u201370 (2012).","journal-title":"Nature"},{"key":"70816_CR3","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","volume":"159","author":"N Cancer Genome Atlas Research","year":"2014","unstructured":"Cancer Genome Atlas Research, N. Integrated genomic characterization of papillary thyroid carcinoma. Cell 159, 676\u2013690 (2014).","journal-title":"Cell"},{"key":"70816_CR4","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature11233","volume":"489","author":"S Djebali","year":"2012","unstructured":"Djebali, S. et al. Landscape of transcription in human cells. Nature 489, 101\u2013108 (2012).","journal-title":"Nature"},{"key":"70816_CR5","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.ccell.2016.03.010","volume":"29","author":"AM Schmitt","year":"2016","unstructured":"Schmitt, A. M. & Chang, H. Y. Long noncoding RNAs in cancer pathways. Cancer Cell 29, 452\u2013463 (2016).","journal-title":"Cancer Cell"},{"key":"70816_CR6","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/ng.3192","volume":"47","author":"MK Iyer","year":"2015","unstructured":"Iyer, M. K. et al. The landscape of long noncoding RNAs in the human transcriptome. Nat. Genet. 47, 199\u2013208 (2015).","journal-title":"Nat. Genet."},{"key":"70816_CR7","doi-asserted-by":"publisher","first-page":"e1002192","DOI":"10.1371\/journal.pmed.1002192","volume":"13","author":"BJ Reon","year":"2016","unstructured":"Reon, B. J. et al. Expression of lncRNAs in low-grade gliomas and glioblastoma multiforme: an in silico analysis. PLoS Med. 13, e1002192 (2016).","journal-title":"PLoS Med."},{"key":"70816_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-015-0230-7","volume":"7","author":"A Verma","year":"2015","unstructured":"Verma, A. et al. Transcriptome sequencing reveals thousands of novel long non-coding RNAs in B cell lymphoma. Genome Med. 7, 110 (2015).","journal-title":"Genome Med."},{"key":"70816_CR9","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.ccell.2018.03.006","volume":"33","author":"Z Wang","year":"2018","unstructured":"Wang, Z. et al. lncRNA epigenetic landscape analysis identifies EPIC1 as an oncogenic lncRNA that interacts with MYC and promotes cell-cycle progression in cancer. Cancer Cell 33, 706\u2013720.e709 (2018).","journal-title":"Cancer Cell"},{"key":"70816_CR10","doi-asserted-by":"publisher","first-page":"41045","DOI":"10.18632\/oncotarget.5728","volume":"6","author":"D Wang","year":"2015","unstructured":"Wang, D. et al. LncRNA MALAT1 enhances oncogenic activities of EZH2 in castration-resistant prostate cancer. Oncotarget 6, 41045\u201341055 (2015).","journal-title":"Oncotarget"},{"key":"70816_CR11","doi-asserted-by":"publisher","first-page":"5275","DOI":"10.1172\/JCI72124","volume":"124","author":"M Marques Howarth","year":"2014","unstructured":"Marques Howarth, M. et al. Long noncoding RNA EWSAT1-mediated gene repression facilitates Ewing sarcoma oncogenesis. J. Clin. Invest. 124, 5275\u20135290 (2014).","journal-title":"J. Clin. Invest."},{"key":"70816_CR12","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.devcel.2009.03.006","volume":"16","author":"R Agrelo","year":"2009","unstructured":"Agrelo, R. et al. SATB1 defines the developmental context for gene silencing by Xist in lymphoma and embryonic cells. Dev. Cell 16, 507\u2013516 (2009).","journal-title":"Dev. Cell"},{"key":"70816_CR13","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.cell.2015.12.017","volume":"164","author":"S Lee","year":"2016","unstructured":"Lee, S. et al. Noncoding RNA NORAD regulates genomic stability by sequestering PUMILIO Proteins. Cell 164, 69\u201380 (2016).","journal-title":"Cell"},{"key":"70816_CR14","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1101\/gr.152942.112","volume":"23","author":"H Ling","year":"2013","unstructured":"Ling, H. et al. CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer. Genome Res. 23, 1446\u20131461 (2013).","journal-title":"Genome Res."},{"key":"70816_CR15","doi-asserted-by":"publisher","first-page":"e1011314","DOI":"10.1371\/journal.pgen.1011314","volume":"20","author":"K Tsung","year":"2024","unstructured":"Tsung, K. et al. CRISPRi screen of long non-coding RNAs identifies LINC03045 regulating glioblastoma invasion. PLoS Genet. 20, e1011314 (2024).","journal-title":"PLoS Genet."},{"key":"70816_CR16","doi-asserted-by":"publisher","first-page":"22020","DOI":"10.1073\/pnas.1909998116","volume":"116","author":"A Nath","year":"2019","unstructured":"Nath, A. et al. Discovering long noncoding RNA predictors of anticancer drug sensitivity beyond protein-coding genes. Proc. Natl. Acad. Sci. USA 116, 22020\u201322029 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"70816_CR17","doi-asserted-by":"publisher","first-page":"265","DOI":"10.7150\/thno.36045","volume":"10","author":"X Deng","year":"2020","unstructured":"Deng, X. et al. Long noncoding RNA PiHL regulates p53 protein stability through GRWD1\/RPL11\/MDM2 axis in colorectal cancer. Theranostics 10, 265\u2013280 (2020).","journal-title":"Theranostics"},{"key":"70816_CR18","doi-asserted-by":"publisher","first-page":"4399","DOI":"10.1158\/0008-5472.CAN-20-1031","volume":"80","author":"Z Fang","year":"2020","unstructured":"Fang, Z. et al. ERINA is an estrogen-responsive LncRNA that drives breast cancer through the E2F1\/RB1 Pathway. Cancer Res. 80, 4399\u20134413 (2020).","journal-title":"Cancer Res."},{"key":"70816_CR19","doi-asserted-by":"publisher","first-page":"eadd0005","DOI":"10.1126\/sciadv.add0005","volume":"8","author":"Y Wang","year":"2022","unstructured":"Wang, Y. et al. Genome-wide gain-of-function screening characterized lncRNA regulators for tumor immune response. Sci. Adv. 8, eadd0005 (2022).","journal-title":"Sci. Adv."},{"key":"70816_CR20","doi-asserted-by":"publisher","first-page":"eabb3555","DOI":"10.1126\/sciadv.abb3555","volume":"7","author":"W Guo","year":"2021","unstructured":"Guo, W. et al. LincRNA-immunity landscape analysis identifies EPIC1 as a regulator of tumor immune evasion and immunotherapy resistance. Sci. Adv. 7, eabb3555 (2021).","journal-title":"Sci. Adv."},{"key":"70816_CR21","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1038\/onc.2015.340","volume":"35","author":"X Xue","year":"2016","unstructured":"Xue, X. et al. LncRNA HOTAIR enhances ER signaling and confers tamoxifen resistance in breast cancer. Oncogene 35, 2746\u20132755 (2016).","journal-title":"Oncogene"},{"key":"70816_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05495-9","volume":"9","author":"Y Wang","year":"2018","unstructured":"Wang, Y. et al. Systematic identification of non-coding pharmacogenomic landscape in cancer. Nat. Commun. 9, 3192 (2018).","journal-title":"Nat. Commun."},{"key":"70816_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-932","volume":"14","author":"Y Han","year":"2014","unstructured":"Han, Y. et al. LEIGC long non-coding RNA acts as a tumor suppressor in gastric carcinoma by inhibiting the epithelial-to-mesenchymal transition. BMC Cancer 14, 932 (2014).","journal-title":"BMC Cancer"},{"key":"70816_CR24","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1016\/j.cell.2022.05.013","volume":"185","author":"JM Replogle","year":"2022","unstructured":"Replogle, J. M. et al. Mapping information-rich genotype-phenotype landscapes with genome-scale perturb-seq. Cell 185, 2559\u20132575.e2528 (2022).","journal-title":"Cell"},{"key":"70816_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41597-020-00659-z","volume":"7","author":"F Seifuddin","year":"2020","unstructured":"Seifuddin, F. et al. lncRNAKB, a knowledgebase of tissue-specific functional annotation and trait association of long noncoding RNA. Sci. Data 7, 326 (2020).","journal-title":"Sci. Data"},{"key":"70816_CR26","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41588-022-01014-1","volume":"54","author":"P Johnsson","year":"2022","unstructured":"Johnsson, P. et al. Transcriptional kinetics and molecular functions of long noncoding RNAs. Nat. Genet. 54, 306\u2013317 (2022).","journal-title":"Nat. Genet."},{"key":"70816_CR27","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nrg.2017.97","volume":"19","author":"JG Doench","year":"2018","unstructured":"Doench, J. G. Am I ready for CRISPR? A user\u2019s guide to genetic screens. Nat. Rev. Genet. 19, 67\u201380 (2018).","journal-title":"Nat. Rev. Genet."},{"key":"70816_CR28","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3892\/ijmm.2022.5184","volume":"50","author":"J Huang","year":"2022","unstructured":"Huang, J., Zheng, L., Sun, Z. & Li, J. CDK4\/6 inhibitor resistance mechanisms and treatment strategies (Review). Int. J. Mol. Med. 50, 128 (2022).","journal-title":"Int. J. Mol. Med."},{"key":"70816_CR29","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1038\/s41417-024-00747-x","volume":"31","author":"X Wang","year":"2024","unstructured":"Wang, X. et al. Recent progress of CDK4\/6 inhibitors\u2019 current practice in breast cancer. Cancer Gene Ther. 31, 1283\u20131291 (2024).","journal-title":"Cancer Gene Ther."},{"key":"70816_CR30","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nature23451","volume":"548","author":"J Joung","year":"2017","unstructured":"Joung, J. et al. Genome-scale activation screen identifies a lncRNA locus regulating a gene neighbourhood. Nature 548, 343\u2013346 (2017).","journal-title":"Nature"},{"key":"70816_CR31","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nature11003","volume":"483","author":"J Barretina","year":"2012","unstructured":"Barretina, J. et al. The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483, 603\u2013607 (2012).","journal-title":"Nature"},{"key":"70816_CR32","doi-asserted-by":"publisher","first-page":"D955","DOI":"10.1093\/nar\/gks1111","volume":"41","author":"W Yang","year":"2013","unstructured":"Yang, W. et al. Genomics of drug sensitivity in cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res. 41, D955\u2013D961 (2013).","journal-title":"Nucleic Acids Res."},{"key":"70816_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-023-01201-7","volume":"15","author":"YH Park","year":"2023","unstructured":"Park, Y. H. et al. Longitudinal multi-omics study of palbociclib resistance in HR-positive\/HER2-negative metastatic breast cancer. Genome Med. 15, 55 (2023).","journal-title":"Genome Med."},{"key":"70816_CR34","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1158\/2159-8290.CD-18-0830","volume":"10","author":"C Costa","year":"2020","unstructured":"Costa, C. et al. PTEN loss mediates clinical cross-resistance to CDK4\/6 and PI3K\u03b1 inhibitors in breast cancer. Cancer Discov. 10, 72\u201385 (2020).","journal-title":"Cancer Discov."},{"key":"70816_CR35","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1158\/1535-7163.MCT-19-0231","volume":"18","author":"WB Kietzman","year":"2019","unstructured":"Kietzman, W. B. et al. Short- and long-term Effects of CDK4\/6 inhibition on early-stage breast cancer. Mol. Cancer Ther. 18, 2220\u20132232 (2019).","journal-title":"Mol. Cancer Ther."},{"key":"70816_CR36","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.cell.2013.08.062","volume":"155","author":"SabrinaL Spencer","year":"2013","unstructured":"Spencer, S. abrinaL. et al. The proliferation-quiescence decision is controlled by a bifurcation in CDK2 activity at mitotic exit. Cell 155, 369\u2013383 (2013).","journal-title":"Cell"},{"key":"70816_CR37","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.cell.2004.08.002","volume":"118","author":"M Malumbres","year":"2004","unstructured":"Malumbres, M. et al. Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6. Cell 118, 493\u2013504 (2004).","journal-title":"Cell"},{"key":"70816_CR38","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1177\/1947601913478972","volume":"3","author":"SJ Baker","year":"2012","unstructured":"Baker, S. J. & Reddy, E. P. CDK4: a key player in the cell cycle, development, and cancer. Genes Cancer 3, 658\u2013669 (2012).","journal-title":"Genes Cancer"},{"key":"70816_CR39","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1002\/jcp.26816","volume":"234","author":"H Zhang","year":"2019","unstructured":"Zhang, H. et al. Effect of CCNB1 silencing on cell cycle, senescence, and apoptosis through the p53 signaling pathway in pancreatic cancer. J. Cell. Physiol. 234, 619\u2013631 (2019).","journal-title":"J. Cell. Physiol."},{"key":"70816_CR40","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/j.1750-3639.1999.tb00532.x","volume":"9","author":"R B\u00fcschges","year":"1999","unstructured":"B\u00fcschges, R. et al. Amplification and expression of cyclin D genes (CCND1 CCND2 and CCND3) in human malignant gliomas. Brain Pathol. 9, 435\u2013442 (1999).","journal-title":"Brain Pathol."},{"key":"70816_CR41","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1002\/humu.10172","volume":"21","author":"J B\u00e9nard","year":"2003","unstructured":"B\u00e9nard, J., Douc-Rasy, S. & Ahomadegbe, J.-C. TP53 family members and human cancers. Hum. Mutat. 21, 182\u2013191 (2003).","journal-title":"Hum. Mutat."},{"key":"70816_CR42","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nrclinonc.2016.26","volume":"13","author":"B O\u2019Leary","year":"2016","unstructured":"O\u2019Leary, B., Finn, R. S. & Turner, N. C. Treating cancer with selective CDK4\/6 inhibitors. Nat. Rev. Clin. Oncol. 13, 417\u2013430 (2016).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"70816_CR43","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41419-025-07354-0","volume":"16","author":"J Cao","year":"2025","unstructured":"Cao, J. et al. Targeting estrogen-regulated system xc\u2212 promotes ferroptosis and endocrine sensitivity of ER+ breast cancer. Cell Death Dis. 16, 30 (2025).","journal-title":"Cell Death Dis."},{"key":"70816_CR44","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3390\/receptors3020010","volume":"3","author":"H Nagandla","year":"2024","unstructured":"Nagandla, H. & Thomas, C. A.-O. Estrogen signals through ER\u03b2 in breast cancer; what we have learned since the discovery of the receptor. Receptors (Basel) 3, 182\u2013200 (2024).","journal-title":"Receptors (Basel)"},{"key":"70816_CR45","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1634\/theoncologist.2014-0443","volume":"20","author":"CG Murphy","year":"2015","unstructured":"Murphy, C. G. & Dickler, M. N. The role of CDK4\/6 inhibition in breast cancer.  Oncologist 20, 483\u2013490 (2015).","journal-title":"Oncologist"},{"key":"70816_CR46","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.ccell.2020.03.010","volume":"37","author":"M \u00c1lvarez-Fern\u00e1ndez","year":"2020","unstructured":"\u00c1lvarez-Fern\u00e1ndez, M. & Malumbres, M. Mechanisms of sensitivity and resistance to CDK4\/6 inhibition. Cancer Cell 37, 514\u2013529 (2020).","journal-title":"Cancer Cell"},{"key":"70816_CR47","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/s43018-021-00215-7","volume":"2","author":"JI Griffiths","year":"2021","unstructured":"Griffiths, J. I. et al. Serial single-cell genomics reveals convergent subclonal evolution of resistance as patients with early-stage breast cancer progress on endocrine plus CDK4\/6 therapy. Nat. Cancer 2, 658\u2013671 (2021).","journal-title":"Nat. Cancer"},{"key":"70816_CR48","doi-asserted-by":"publisher","first-page":"3264","DOI":"10.1158\/0008-5472.CAN-23-0705","volume":"83","author":"J Navarro-Yepes","year":"2023","unstructured":"Navarro-Yepes, J. et al. Abemaciclib is effective in palbociclib-resistant hormone receptor-positive metastatic breast cancers. Cancer Res. 83, 3264\u20133283 (2023).","journal-title":"Cancer Res."},{"key":"70816_CR49","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.cllc.2015.08.003","volume":"17","author":"JW Goldman","year":"2015","unstructured":"Goldman, J. W. et al. Treatment rationale and study design for the JUNIPER study: a randomized phase III study of abemaciclib with best supportive care versus erlotinib with best supportive care in patients with stage IV non-small-cell lung cancer with a detectable KRAS mutation whose disease has progressed after platinum-based chemotherapy. Clin. Lung Cancer 17, 80\u201384 (2015).","journal-title":"Clin. Lung Cancer"},{"key":"70816_CR50","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1158\/1078-0432.CCR-16-2898","volume":"23","author":"B Geoerger","year":"2017","unstructured":"Geoerger, B. et al. A phase I study of the CDK4\/6 inhibitor ribociclib (LEE011) in pediatric patients with malignant rhabdoid tumors, neuroblastoma, and other solid tumors. Clin. Cancer Res. 23, 2433\u20132441 (2017).","journal-title":"Clin. Cancer Res."},{"key":"70816_CR51","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1158\/2159-8290.CD-16-0095","volume":"6","author":"A Patnaik","year":"2016","unstructured":"Patnaik, A. et al. Efficacy and safety of abemaciclib, an inhibitor of CDK4 and CDK6, for patients with breast cancer, non-small cell lung cancer, and other solid tumors. Cancer Discov. 6, 740\u2013753 (2016).","journal-title":"Cancer Discov."},{"key":"70816_CR52","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1056\/NEJMoa1607303","volume":"375","author":"S Finn Richard","year":"2016","unstructured":"Finn Richard, S. et al. Palbociclib and letrozole in advanced breast cancer. N. Engl. J. Med. 375, 1925\u20131936 (2016).","journal-title":"N. Engl. J. Med."},{"key":"70816_CR53","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1056\/NEJMoa1505270","volume":"373","author":"NC Turner","year":"2015","unstructured":"Turner, N. C. et al. Palbociclib in hormone-receptor-positive advanced breast cancer. N. Engl. J. Med. 373, 209\u2013219 (2015).","journal-title":"N. Engl. J. Med."},{"key":"70816_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2419","volume":"11","author":"RS Finn","year":"2009","unstructured":"Finn, R. S. et al. PD 0332991, a selective cyclin D kinase 4\/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro. Breast Cancer Res. 11, R77 (2009).","journal-title":"Breast Cancer Res."},{"key":"70816_CR55","doi-asserted-by":"publisher","first-page":"4947","DOI":"10.1158\/1078-0432.CCR-14-2955","volume":"21","author":"ME Olanich","year":"2015","unstructured":"Olanich, M. E. et al. CDK4 amplification reduces sensitivity to CDK4\/6 inhibition in fusion-positive rhabdomyosarcoma. Clin. Cancer Res. 21, 4947\u20134959 (2015).","journal-title":"Clin. Cancer Res."},{"key":"70816_CR56","doi-asserted-by":"publisher","first-page":"4611","DOI":"10.1158\/1078-0432.CCR-18-3127","volume":"25","author":"M Toulmonde","year":"2019","unstructured":"Toulmonde, M. et al. Activity and safety of palbociclib in patients with advanced gastrointestinal stromal tumors refractory to imatinib and sunitinib: a biomarker-driven phase II study. Clin. Cancer Res. 25, 4611\u20134615 (2019).","journal-title":"Clin. Cancer Res."},{"key":"70816_CR57","doi-asserted-by":"publisher","first-page":"4597","DOI":"10.1182\/blood-2011-10-388298","volume":"119","author":"JP Leonard","year":"2012","unstructured":"Leonard, J. P. et al. Selective CDK4\/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma. Blood 119, 4597\u20134607 (2012).","journal-title":"Blood"},{"key":"70816_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07901-8","volume":"9","author":"KR Sanson","year":"2018","unstructured":"Sanson, K. R. et al. Optimized libraries for CRISPR-Cas9 genetic screens with multiple modalities. Nat. Commun. 9, 5416 (2018).","journal-title":"Nat. Commun."},{"key":"70816_CR59","doi-asserted-by":"publisher","first-page":"3802","DOI":"10.1158\/1078-0432.CCR-16-1501","volume":"23","author":"CL Andersen","year":"2017","unstructured":"Andersen, C. L. et al. Active estrogen receptor-alpha signaling in ovarian cancer models and clinical specimens. Clin. Cancer Res. 23, 3802\u20133812 (2017).","journal-title":"Clin. Cancer Res."},{"key":"70816_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-020-00563-4","volume":"18","author":"Z Chen","year":"2020","unstructured":"Chen, Z. et al. Estrogen-ER\u03b1 signaling and DNA hypomethylation co-regulate expression of stem cell protein PIWIL1 in ER\u03b1-positive endometrial cancer cells. Cell Commun. Signal. 18, 84 (2020).","journal-title":"Cell Commun. Signal."},{"key":"70816_CR61","doi-asserted-by":"publisher","unstructured":"Lafront, C. et al. The estrogen signaling pathway reprograms prostate cancer cell metabolism and supports proliferation and disease progression. J. Clin. Invest. https:\/\/doi.org\/10.1172\/JCI170809 (2024).","DOI":"10.1172\/JCI170809"},{"key":"70816_CR62","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1002\/1878-0261.12701","volume":"14","author":"M He","year":"2020","unstructured":"He, M. et al. Estrogen receptor \u03b1 promotes lung cancer cell invasion via increase of and cross-talk with infiltrated macrophages through the CCL2\/CCR2\/MMP9 and CXCL12\/CXCR4 signaling pathways. Mol. Oncol. 14, 1779\u20131799 (2020).","journal-title":"Mol. Oncol."},{"key":"70816_CR63","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.steroids.2018.02.007","volume":"134","author":"H You","year":"2018","unstructured":"You, H., Meng, K. & Wang, Z.-Y. The ER-\u03b136\/EGFR signaling loop promotes growth of hepatocellular carcinoma cells. Steroids 134, 78\u201387 (2018).","journal-title":"Steroids"},{"key":"70816_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01582-1","volume":"22","author":"G Topi","year":"2024","unstructured":"Topi, G. et al. High Oestrogen receptor alpha expression correlates with adverse prognosis and promotes metastasis in colorectal cancer. Cell Commun. Signal. 22, 198 (2024).","journal-title":"Cell Commun. Signal."},{"key":"70816_CR65","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1080\/15384101.2016.1166327","volume":"15","author":"S JavanMoghadam","year":"2016","unstructured":"JavanMoghadam, S., Weihua, Z., Hunt, K. K. & Keyomarsi, K. Estrogen receptor alpha is cell cycle-regulated and regulates the cell cycle in a ligand-dependent fashion. Cell Cycle 15, 1579\u20131590 (2016).","journal-title":"Cell Cycle"},{"key":"70816_CR66","doi-asserted-by":"publisher","first-page":"e38406","DOI":"10.1016\/j.heliyon.2024.e38406","volume":"10","author":"MM Heldring","year":"2024","unstructured":"Heldring, M. M. et al. Interdependency of estradiol-mediated ER\u03b1 activation and subsequent PR and GREB1 induction to control cell cycle progression. Heliyon 10, e38406 (2024).","journal-title":"Heliyon"},{"key":"70816_CR67","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1016\/j.molcel.2024.08.021","volume":"84","author":"JE Henninger","year":"2024","unstructured":"Henninger, J. E. & Young, R. A. An RNA-centric view of transcription and genome organization. Mol. Cell 84, 3627\u20133643 (2024).","journal-title":"Mol. Cell"},{"key":"70816_CR68","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1016\/j.molcel.2023.06.012","volume":"83","author":"O Oksuz","year":"2023","unstructured":"Oksuz, O. et al. Transcription factors interact with RNA to regulate genes. Mol. Cell 83, 2449\u20132463.e2413 (2023).","journal-title":"Mol. Cell"},{"key":"70816_CR69","doi-asserted-by":"publisher","unstructured":"Li, S. et al. Integrative characterization of MYC RNA-binding function. Cell Genomics https:\/\/doi.org\/10.1016\/j.xgen.2025.100878 (2025).","DOI":"10.1016\/j.xgen.2025.100878"},{"key":"70816_CR70","doi-asserted-by":"publisher","unstructured":"Wang, X. et al. Cytoplasmic PXR regulates glucose metabolism by binding mRNAs and modulating their stability. Nat. Struct. Mol. Biol. https:\/\/doi.org\/10.1038\/s41594-025-01614-5 (2025).","DOI":"10.1038\/s41594-025-01614-5"},{"key":"70816_CR71","doi-asserted-by":"publisher","first-page":"5215","DOI":"10.1016\/j.cell.2021.08.036","volume":"184","author":"Y Xu","year":"2021","unstructured":"Xu, Y. et al. ERa is an RNA-binding protein sustaining tumor cell survival drug resistance. Cell 184, 5215\u20135229.e5217 (2021).","journal-title":"Cell"},{"key":"70816_CR72","doi-asserted-by":"publisher","first-page":"5186","DOI":"10.1038\/s44318-024-00225-y","volume":"43","author":"D Soota","year":"2024","unstructured":"Soota, D., Saravanan, B., Mann, R., Kharbanda, T. & Notani, D. RNA fine-tunes estrogen receptor-alpha binding on low-affinity DNA motifs for transcriptional regulation. EMBO J. 43, 5186\u20135210-5210 (2024).","journal-title":"EMBO J."},{"key":"70816_CR73","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/nprot.2017.016","volume":"12","author":"J Joung","year":"2017","unstructured":"Joung, J. et al. Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening. Nat. Protoc. 12, 828\u2013863 (2017).","journal-title":"Nat. Protoc."},{"key":"70816_CR74","doi-asserted-by":"publisher","first-page":"D876","DOI":"10.1093\/nar\/gkq963","volume":"39","author":"PA Fujita","year":"2011","unstructured":"Fujita, P. A. et al. The UCSC Genome Browser database: update 2011. Nucleic Acids Res. 39, D876\u2013D882 (2011).","journal-title":"Nucleic Acids Res."},{"key":"70816_CR75","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-015-0843-6","volume":"16","author":"W Li","year":"2015","unstructured":"Li, W. et al. Quality control, modeling, and visualization of CRISPR screens with MAGeCK-VISPR. Genome Biol. 16, 281 (2015).","journal-title":"Genome Biol."},{"key":"70816_CR76","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/ng.2764","volume":"45","author":"K Chang","year":"2013","unstructured":"Chang, K. et al. The Cancer Genome Atlas Pan-cancer analysis project. Nat. Genet. 45, 1113\u20131120 (2013).","journal-title":"Nat. Genet."},{"key":"70816_CR77","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/ng.2653","volume":"45","author":"J Lonsdale","year":"2013","unstructured":"Lonsdale, J. et al. The genotype-tissue expression (GTEx) project. Nat. Genet. 45, 580\u2013585 (2013).","journal-title":"Nat. Genet."},{"key":"70816_CR78","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"70816_CR79","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-323","volume":"12","author":"B Li","year":"2011","unstructured":"Li, B. & Dewey, C. N. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinforma. 12, 323 (2011).","journal-title":"BMC Bioinforma."},{"key":"70816_CR80","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2010-11-10-r106","volume":"11","author":"S Anders","year":"2010","unstructured":"Anders, S. & Huber, W. Differential expression analysis for sequence count data. Genome Biol. 11, R106 (2010).","journal-title":"Genome Biol."},{"key":"70816_CR81","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox, D. R. Regression models and life-tables. J. R. Stat. Soc.: Ser. B (Methodol.) 34, 187\u2013202 (1972).","journal-title":"J. R. Stat. Soc.: Ser. B (Methodol.)"},{"key":"70816_CR82","doi-asserted-by":"publisher","unstructured":"Zhao, Y. Code Repository for CRISPRa_cdkscreen. GitHub https:\/\/doi.org\/10.5281\/zenodo.18118851 (2026).","DOI":"10.5281\/zenodo.18118851"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70816-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70816-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70816-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:04:15Z","timestamp":1782173055000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70816-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["70816"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-70816-2","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,9]]},"assertion":[{"value":"4 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5512"}}